BridgeBio Pharma, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for genetic diseases and rare disorders. Headquartered in Palo Alto, California, BridgeBio leverages its innovative approach to drug development, employing advanced scientific methodologies to address unmet medical needs. With a robust pipeline of product candidates and a commitment to improving patient outcomes, BridgeBio is positioned as a leader in the genetic medicine landscape.
Click "Analyze" to generate stock analysis
BBIO Price Trend and Signals
BBIO Option Volumes & Open Interests (aggregated)
BBIO Put Call Ratios and IV (aggregated)
BBIO Financials
2025-10-29Somewhat Bullishprice_signal
Yearly high detected.
2025-10-28Somewhat Bullishprice_signal
Yearly high detected.
2025-10-27Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-27Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.